A description is not currently available for this report.
Report Content Chapter 1 Methodology & Scope 1.1 Market scope & definitions 1.2 Research design 1.2.1 Research approach 1.2.2 Data collection methods 1.3 Base estimates & calculations 1.3.1 Base year calculation 1.3.2 Key trends for market estimation 1.4 Forecast model 1.5 Primary research and validation 1.5.1 Primary sources 1.5.2 Data mining sources Chapter 2 Executive Summary 2.1 Industry 360 degree synopsis Chapter 3 Industry Insights 3.1 Industry ecosystem analysis 3.2 Industry impact forces 3.2.1 Growth drivers 3.2.1.1 Increase in the prevalence of chronic pain 3.2.1.2 Increase in incident of trauma and surgeries 3.2.1.3 Rise in geriatric population 3.2.1.4 Advancement in drug delivery system 3.2.2 Industry pitfalls & challenges 3.2.2.1 Regulatory restrictions 3.2.2.2 Alternative pain management technologies 3.3 Growth potential analysis 3.4 Regulatory landscape 3.5 Porter's analysis 3.6 PESTEL analysis Chapter 4 Competitive Landscape, 2023 4.1 Introduction 4.2 Company market share analysis 4.3 Company matrix analysis 4.4 Competitive analysis of major market players 4.5 Competitive positioning matrix 4.6 Strategic dashboard Chapter 5 Market Estimates and Forecast, By Drug Type, 2021 - 2032 ($ Mn) 5.1 Key trends 5.2 Short-acting oxycodone 5.3 Long-acting oxycodone Chapter 6 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn) 6.1 Key trends 6.2 Tablets 6.3 Capsules 6.4 Injections Chapter 7 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn) 7.1 Key trends 7.2 Neuropathic pain 7.3 Musculoskeletal pain 7.4 Cancer pain 7.5 Post-operative pain 7.6 Other indications Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn) 8.1 Key trends 8.2 Hospital pharmacies 8.3 Drug stores & retail pharmacies 8.4 Online pharmacies Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn) 9.1 Key trends 9.2 North America 9.2.1 U.S. 9.2.2 Canada 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 France 9.3.4 Spain 9.3.5 Italy 9.3.6 Netherlands 9.3.7 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 South Korea 9.4.6 Rest of Asia Pacific 9.5 Latin America 9.5.1 Brazil 9.5.2 Mexico 9.5.3 Rest of Latin America 9.6 Middle East and Africa 9.6.1 South Africa 9.6.2 Saudi Arabia 9.6.3 UAE 9.6.4 Rest of Middle East and Africa Chapter 10 Company Profiles 10.1 Alvogen 10.2 Ani Pharmaceutical Inc. 10.3 Daiichi Sankyo Company Ltd. 10.4 Endo Pharmaceuticals 10.5 Mallinckrodt Pharmaceuticals 10.6 Mylan N.V. 10.7 Protega Pharmaceuticals LLC 10.8 Purdue Pharma LP 10.9 Quagen Pharma 10.10 Teva Pharmaceuticals, Inc.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook